India Regulatory & Tax Advisory for Healthcare and Life Sciences Companies

India's Healthcare Opportunity and Regulatory Complexity

India is the world's largest generic pharmaceutical producer and a rapidly growing medical devices market. The combination of manufacturing cost advantages, a large patient population, and a skilled scientific workforce makes India a strategic priority for global healthcare and life sciences companies. However, the sector operates under a complex web of regulators — CDSCO (Central Drugs Standard Control Organisation), the Ministry of Health, state drug controllers, and the Drugs and Cosmetics Act — alongside standard FEMA, tax, and corporate compliance requirements.

Services for Healthcare & Life Sciences Companies

Subsidiary Formation for Pharma & Medical Device Companies

Foreign pharmaceutical and medical device companies entering India typically establish a wholly owned subsidiary (Private Limited Company) for manufacturing, distribution, or R&D activities. We handle the complete incorporation process, including FDI compliance under the healthcare sector's automatic route (up to 100% FDI in manufacturing, up to 26% in brownfield pharma under automatic route). For manufacturing entities, we advise on the interaction between corporate structure and licensing requirements under the Drugs and Cosmetics Act.

Transfer Pricing for Clinical Trials & Pharma R&D

Contract research organisations (CROs), clinical trial agreements, and pharmaceutical R&D cost-sharing arrangements between Indian entities and overseas affiliates are subject to India's transfer pricing regulations. The arm's length pricing of R&D services, IP licensing for pharmaceutical compounds, and clinical data-sharing agreements requires specialist benchmarking. We prepare transfer pricing documentation and defend positions in TP assessments before the Indian Tax Department.

GST for Medical Devices & Pharmaceutical Products

GST rates for healthcare products vary significantly — many life-saving medicines are at 5% or nil, while medical devices (classified as goods under GST) attract varying rates from 5% to 18% depending on HS classification. Healthcare services are largely GST-exempt, but digital health platforms, diagnostic services, and medical tourism facilitation services can have complex GST treatment. We manage GST classification, registration, and compliance for healthcare companies across the value chain.

FEMA Compliance for Healthcare FDI

Healthcare sector FDI in India has specific conditions, particularly for brownfield pharmaceutical acquisitions where government approval is required above 26%. We advise on the FDI regulatory framework for hospitals, diagnostics, pharmaceutical manufacturing, and medical devices, and manage all FEMA reporting including FC-GPR, APR, and capital account transactions.

Virtual CFO for Healthcare Startups & Scale-ups

Digital health startups, diagnostic chains, and medtech companies require financial leadership that understands healthcare sector economics — capex-intensive infrastructure, regulated pricing, insurance reimbursement cycles, and complex EBITDA structures. Our Virtual CFO service provides monthly financial management, board reporting, and investor-grade compliance for healthcare companies at every growth stage.

Enquire About Healthcare Sector Advisory